These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19410162)

  • 21. Approach to the patient with prediabetes.
    Aroda VR; Ratner R
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3259-65. PubMed ID: 18772457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of therapeutic interventions to prevent Type 2 diabetes in Canada.
    Caro JJ; Getsios D; Caro I; Klittich WS; O'Brien JA
    Diabet Med; 2004 Nov; 21(11):1229-36. PubMed ID: 15498090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES).
    Armato JP; DeFronzo RA; Abdul-Ghani M; Ruby RJ
    Lancet Diabetes Endocrinol; 2018 Oct; 6(10):781-789. PubMed ID: 30224284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network Meta-analysis of the Therapeutic Effects of Hypoglycemic Drugs and Intensive Lifestyle Modification on Impaired Glucose Tolerance.
    Zhang Y; Fu Y; Mu YM; Huang Y; Xuan J
    Clin Ther; 2021 Sep; 43(9):1524-1556. PubMed ID: 34452739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Is it possible to prevent type 2 diabetes?].
    Laville M
    Ann Endocrinol (Paris); 2003 Jun; 64(3 Suppl):S37-44. PubMed ID: 12910058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal glycemic profiles by CGMS in obese first-degree relatives of type 2 diabetes mellitus patients.
    Madhu SV; Muduli SK; Avasthi R
    Diabetes Technol Ther; 2013 Jun; 15(6):461-5. PubMed ID: 23631606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic implications of diabetes in cardiovascular disease.
    Cherian B; Meka N; Katragadda S; Arora R
    Am J Ther; 2009; 16(6):e51-9. PubMed ID: 19940606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidiabetic agents in subjects with mild dysglycaemia: prevention or early treatment of type 2 diabetes?
    Scheen AJ
    Diabetes Metab; 2007 Feb; 33(1):3-12. PubMed ID: 17258489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of Type 2 diabetes: fact or fiction?
    Chiasson JL
    Expert Opin Pharmacother; 2007 Dec; 8(18):3147-58. PubMed ID: 18035959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacotherapeutic options for prediabetes.
    Rendell M
    Expert Opin Pharmacother; 2021 Jan; 22(1):45-54. PubMed ID: 32892663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preservation of β-cell function: the key to diabetes prevention.
    DeFronzo RA; Abdul-Ghani MA
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of orlistat in controlling the progression of prediabetes to diabetes: A meta-analysis and systematic review.
    Gao Z; Huang M; Wang J; Jia H; Lv P; Zeng J; Ti G
    Medicine (Baltimore); 2024 May; 103(21):e38354. PubMed ID: 38787971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of lifestyle interventions on glucose regulation and diabetes risk in adults with impaired glucose tolerance or prediabetes: a meta-analysis.
    Jiang Q; Li JT; Sun P; Wang LL; Sun LZ; Pang SG
    Arch Endocrinol Metab; 2022 Apr; 66(2):157-167. PubMed ID: 35289514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.
    Zinman B; Harris SB; Gerstein HC; Young TK; Raboud JM; Neuman J; Hanley AJ
    Diabetes Obes Metab; 2006 Sep; 8(5):531-7. PubMed ID: 16918588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of various indices derived from an oral glucose tolerance test in the prediction of conversion from prediabetes to type 2 diabetes.
    Kim YA; Ku EJ; Khang AR; Hong ES; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
    Diabetes Res Clin Pract; 2014 Nov; 106(2):351-9. PubMed ID: 25245975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preventing the progression to type 2 diabetes mellitus in adults at high risk: a systematic review and network meta-analysis of lifestyle, pharmacological and surgical interventions.
    Stevens JW; Khunti K; Harvey R; Johnson M; Preston L; Woods HB; Davies M; Goyder E
    Diabetes Res Clin Pract; 2015 Mar; 107(3):320-31. PubMed ID: 25638454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors.
    Tamayo T; Schipf S; Meisinger C; Schunk M; Maier W; Herder C; Roden M; Nauck M; Peters A; Völzke H; Rathmann W
    PLoS One; 2014; 9(11):e113154. PubMed ID: 25402347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacological interventions in the prevention of type 2 diabetes.
    Henness S
    Curr Opin Endocrinol Diabetes Obes; 2007 Apr; 14(2):166-9. PubMed ID: 17940436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.
    Van de Laar FA; Lucassen PL; Akkermans RP; Van de Lisdonk EH; De Grauw WJ
    Cochrane Database Syst Rev; 2006 Oct; (4):CD005061. PubMed ID: 17054235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.